Skip to main content
Equibles

GEODE CAPITAL MANAGEMENT, LLC

Position in AKTS — Aktis Oncology, Inc.

CIK 1214717 BOSTON, MA
Back to AKTS Full portfolio

Position in AKTS

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$16,783,353
+$7,982,619 QoQ
Shares Held
520,737
+5.9% QoQ
Ownership
0.936%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#16
of 114 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in AKTS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $22,039,482,949 across 521 Biotechnology names. AKTS ranks #151 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 6,017,848 $2,989,245,636
2 REGN
Regeneron Pharmaceuticals, Inc.
 2,625,810 $1,637,297,566
3 ALNY
Alnylam Pharmaceuticals, Inc.
 2,635,840 $793,466,914
4 RVMD
Revolution Medicines, Inc.
 3,942,676 $738,384,360
5 MRNA
Moderna, Inc.
 9,710,335 $680,014,759
6 INCY
Incyte Corp
 4,750,735 $538,543,319
7 RPRX
Royalty Pharma plc
 8,058,048 $451,814,751
8 INSM
INSMED Inc
 4,220,155 $449,952,925

All Filings in AKTS

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $16,783,353 520,737
2026-03-31 $8,800,734 491,936